November 2014
Market Access Summit by Strategy Institute
Neil Palmer will be presenting at the conference on the following topic: Implications of Global Trends on Pharmaceutical Pricing and Reimbursement in Canada
Find out more »January 2015
Phacilitate Washington Cell & Gene Therapy Forum 2015
The Cell & Gene Therapy Forum will further enhance its status as the world’s premier event for the sector's senior decision-makers; the world's first and still largest event focused on defining the successful development and commercialization models for C> products. This January will see an expanded agenda exploring manufacturing, product characterization, logistics, R&D and regulatory challenges and solutions in detail, as well as the second renewal of the associated Stem Cells as Discovery Research Tools stream. Neil Palmer (PDCI's President and Principal Consultant) will be…
Find out more »March 2015
STICKER SHOCK: CHSPR 2015 Annual Health Policy Conference
Finding value in an era of high-priced drugs The pricing of new drugs has always been a controversial subject. New, usually single source, and ever more expensive, treatments appear every year, stoking the controversy to a fever pitch. While “expensive” used to mean hundreds of dollars annually per patient, it can now mean hundreds of thousands of dollars. With prices changing so rapidly, and new products being introduced so frequently, how can we make evidence-informed decisions about what to cover,…
Find out more »The Canadian Institute: Pharma Symposium Canada 2015
PDCI Market Access is happy to be sponsoring the Canadian Institute: Pharma Symposium Canada 2015. This year’s expanded program scope reflects the critical role that timely access to drugs plays in our healthcare system. This event will bring together a greater number of stakeholders from both the public and private sectors to foster collaborative discussions that could, in turn, lead to shorter time in development for new drugs and sustainable prices for payers and manufacturers alike. For more information on the…
Find out more »April 2015
2015 CADTH Symposium
What does the evidence say? --- HTA to Support Policy and Practice The 2015 CADTH Symposium will bring together more than 450 delegates from across Canada who are actively involved in the areas of policy-making, program decision-making, health care delivery, and research. Since 2005, CADTH has hosted an annual symposium to bring together stakeholders interested in the use of evidence to inform decisions about the funding and use of drugs and other health technologies in the Canadian health care system.…
Find out more »WIB-Greater Montreal and the Technoparc Montréal Present a Conference on Drug Reimbursement in Quebec
PDCI Presentation at Women In Bio (Montreal Chapter) – April 16th, 2015 The Greater Montreal Chapter of Women In Bio will present a half-day conference followed by a keynote lunch on the latest developments and trends affecting market access and reimbursement of drugs and other healthcare technologies in Quebec, from 8:30 a.m. - 1:30 p.m., Thursday, April 16, 2015, at the NEOMED Institute. The increasing costs of healthcare, including the cost of new specialty and orphan drugs, are putting an…
Find out more »May 2015
ISPOR 20th Annual International Meeting
Integrating Big Data, Patient Data, and Cost-Effectiveness into Clinical Practice: Promise and Prospects. First Plenary Session: Taking Stock of the Learning Health Care System: What Have We Achieved and Why Does It Matter? Second Plenary Session: Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point? Third Plenary Session: Big Data, Big Systems, and Better Evidence: What Progress? Early Registration Deadline: Tuesday, April 14, 2015 Meeting features over 1750 presentations!
Find out more »July 2015
Pharma Pricing, Reimbursement & Market Access 2015
PDCI’s President and Principal Consultant, Neil Palmer is scheduled to give a presentation at the Pharma Pricing, Reimbursement & Market Access 2015 entitled: "Canada: Latest Developments in Pricing, Reimbursement and Market Access." Topics covered include: • Overview of Canadian health care system and pharmaceutical funding • Public and private drug plan coverage and overview of pCPA (risk sharing) agreement process • Price regulation / PMPRB price guidelines: overview and implications of proposed changes • HTA: CADTH/CDR/pCODR, INESSS – updates on recent initiatives • Implications…
Find out more »September 2015
2nd Cell & Gene Therapy Conference
The 2nd Cell & Gene Therapy Conference will take place September 9-10, 2015 in Philadelphia, PA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues and gain fresh perspective on the various research. Treatment of disease using cell and gene therapy is now a reality. With emerging technologies and new clinical trials being developed and launched at a growing rate, this meeting will discuss the evolving regulatory challenges…
Find out more »